Atara Biotherapeutics
(NASDAQ:ATRA)
$0.7031
0.0031[0.44%]
Last update: 12:47PM Get Real Time Here
Q4 2023 earnings were released today before the market open
Consensus Rating1
Buy
Highest Price Target1
$0.50
Lowest Price Target1
$0.50
Consensus Price Target1
$9.99

Atara Biotherapeutics Stock (NASDAQ:ATRA), Analyst Ratings, Price Targets, Predictions

Atara Biotherapeutics Inc has a consensus price target of $9.99, established from looking at the 25 latest analyst ratings. The last 3 analyst ratings were released from Goldman Sachs, Evercore ISI Group, and HC Wainwright & Co. on November 10, 2023, November 9, 2023, and November 9, 2023. With an average price target of $0.17 between Goldman Sachs, Evercore ISI Group, and HC Wainwright & Co., there's an implied -76.30% downside for Atara Biotherapeutics Inc from these 3 analyst ratings.

Analyst Rating Summary1

Analyst Ratings
Nov 23
2
1
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Goldman Sachs
Evercore ISI Group
HC Wainwright & Co.
Mizuho
HC Wainwright & Co.

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Atara Biotherapeutics

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
11/10/2023ATRABuy Now
Atara Biotherapeutics
$0.70-28.89%Goldman Sachs
Tommie Reerink
$3 → $0.5MaintainsSellGet Alert
11/09/2023ATRABuy Now
Atara Biotherapeutics
$0.70Evercore ISI Group
Michael DiFiore
DowngradeOutperform → In-LineGet Alert
11/09/2023ATRABuy Now
Atara Biotherapeutics
$0.70HC Wainwright & Co.
Robert Burns
DowngradeBuy → NeutralGet Alert
11/09/2023ATRABuy Now
Atara Biotherapeutics
$0.7042.23%Mizuho
Salim Syed
$31 → $1DowngradeBuy → NeutralGet Alert
09/26/2023ATRABuy Now
Atara Biotherapeutics
$0.703882.36%HC Wainwright & Co. → $28ReiteratesBuy → BuyGet Alert
08/21/2023ATRABuy Now
Atara Biotherapeutics
$0.7099.12%Citigroup
Yigal Nochomovitz
$2 → $1.4MaintainsSellGet Alert
08/09/2023ATRABuy Now
Atara Biotherapeutics
$0.703455.68%EF Hutton
Anthony Butler
→ $25ReiteratesBuy → BuyGet Alert
06/14/2023ATRABuy Now
Atara Biotherapeutics
$0.703882.36%HC Wainwright & Co.
Robert Burns
$27 → $28MaintainsBuyGet Alert
05/09/2023ATRABuy Now
Atara Biotherapeutics
$0.702744.55%Canaccord Genuity
John Newman
$50 → $20MaintainsBuyGet Alert
02/09/2023ATRABuy Now
Atara Biotherapeutics
$0.703455.68%EF Hutton
Anthony Butler
→ $25Reiterates → BuyGet Alert
02/09/2023ATRABuy Now
Atara Biotherapeutics
$0.703740.14%HC Wainwright & Co.
Robert Burns
$29 → $27MaintainsBuyGet Alert
02/07/2023ATRABuy Now
Atara Biotherapeutics
$0.704309.05%Mizuho
Salim Syed
→ $31Reiterates → BuyGet Alert
01/05/2023ATRABuy Now
Atara Biotherapeutics
$0.703455.68%EF Hutton
Tony Butler
→ $25Initiates → BuyGet Alert
08/16/2022ATRABuy Now
Atara Biotherapeutics
$0.704309.05%Mizuho
Salim Syed
$39 → $31MaintainsBuyGet Alert
08/09/2022ATRABuy Now
Atara Biotherapeutics
$0.70326.68%Goldman Sachs
Tommie Reerink
$4 → $3MaintainsSellGet Alert
07/20/2022ATRABuy Now
Atara Biotherapeutics
$0.70326.68%Citigroup
Yigal Nochomovitz
→ $3DowngradeNeutral → SellGet Alert
07/13/2022ATRABuy Now
Atara Biotherapeutics
$0.701322.27%JP Morgan
Anupam Rama
→ $10DowngradeOverweight → NeutralGet Alert
07/13/2022ATRABuy Now
Atara Biotherapeutics
$0.70611.14%Stifel
Benjamin Burnett
$16 → $5DowngradeBuy → HoldGet Alert
05/24/2022ATRABuy Now
Atara Biotherapeutics
$0.70468.91%Goldman Sachs
Salveen Richter
$5 → $4MaintainsSellGet Alert

FAQ

Q

What is the target price for Atara Biotherapeutics (ATRA)?

A

The latest price target for Atara Biotherapeutics (NASDAQ: ATRA) was reported by Goldman Sachs on November 10, 2023. The analyst firm set a price target for $0.50 expecting ATRA to fall to within 12 months (a possible -28.89% downside). 9 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Atara Biotherapeutics (ATRA)?

A

The latest analyst rating for Atara Biotherapeutics (NASDAQ: ATRA) was provided by Goldman Sachs, and Atara Biotherapeutics maintained their sell rating.

Q

When was the last upgrade for Atara Biotherapeutics (ATRA)?

A

The last upgrade for Atara Biotherapeutics Inc happened on May 13, 2021 when JP Morgan raised their price target to $29. JP Morgan previously had a neutral for Atara Biotherapeutics Inc.

Q

When was the last downgrade for Atara Biotherapeutics (ATRA)?

A

The last downgrade for Atara Biotherapeutics Inc happened on November 9, 2023 when Evercore ISI Group changed their price target from N/A to N/A for Atara Biotherapeutics Inc.

Q

When is the next analyst rating going to be posted or updated for Atara Biotherapeutics (ATRA)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Atara Biotherapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Atara Biotherapeutics was filed on November 10, 2023 so you should expect the next rating to be made available sometime around November 10, 2024.

Q

Is the Analyst Rating Atara Biotherapeutics (ATRA) correct?

A

While ratings are subjective and will change, the latest Atara Biotherapeutics (ATRA) rating was a maintained with a price target of $3.00 to $0.50. The current price Atara Biotherapeutics (ATRA) is trading at is $0.70, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch